Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Burning Rock Biotech (BNR) over the last 6 years, with Q2 2025 value amounting to $279000.0.

  • Burning Rock Biotech's Cash from Financing Activities changed N/A to $279000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.3 million, marking a year-over-year change of. This contributed to the annual value of -$10000.0 for FY2024, which is 9985.46% up from last year.
  • According to the latest figures from Q2 2025, Burning Rock Biotech's Cash from Financing Activities is $279000.0.
  • In the past 5 years, Burning Rock Biotech's Cash from Financing Activities ranged from a high of $279000.0 in Q2 2025 and a low of -$12.5 million during Q4 2022
  • Over the past 5 years, Burning Rock Biotech's median Cash from Financing Activities value was -$628000.0 (recorded in 2021), while the average stood at -$2.8 million.
  • The largest annual percentage gain for Burning Rock Biotech's Cash from Financing Activities in the last 5 years was 9919.48% (2023), contrasted with its biggest fall of 157706.67% (2023).
  • Over the past 5 years, Burning Rock Biotech's Cash from Financing Activities (Quarter) stood at -$1.1 million in 2021, then tumbled by 1073.99% to -$12.5 million in 2022, then surged by 97.85% to -$269000.0 in 2023, then soared by 96.28% to -$10000.0 in 2024, then surged by 2890.0% to $279000.0 in 2025.
  • Its Cash from Financing Activities was $279000.0 in Q2 2025, compared to -$10000.0 in Q4 2024 and -$269000.0 in Q4 2023.